Publicaciones en las que colabora con RUBEN DARIO ARTERO ALLEPUZ (9)

2023

  1. Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSALR Mice

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  2. The myotonic dystrophy type 1 drug development pipeline: 2022 edition

    Drug Discovery Today, Vol. 28, Núm. 3

2022

  1. Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  2. Role of miRNAs in muscle atrophy: the myotonic dystrophy paradigm

    MicroRNA: From Bench to Bedside (Elsevier), pp. 331-362

2021

  1. Myotonic dystrophy type 1 drug development: A pipeline toward the market

    Drug Discovery Today, Vol. 26, Núm. 7, pp. 1765-1772

2019

  1. MicroRNA-based therapeutic perspectives in myotonic dystrophy

    International Journal of Molecular Sciences, Vol. 20, Núm. 22

2016

  1. Six serum miRNAs fail to validate as myotonic dystrophy type 1 biomarkers

    PLoS ONE, Vol. 11, Núm. 2

2014

  1. Development of a Drosophila melanogaster spliceosensor system for in vivo high-throughput screening in myotonic dystrophy type 1

    DMM Disease Models and Mechanisms, Vol. 7, Núm. 11, pp. 1297-1306

2013

  1. In vivo strategies for drug discovery in myotonic dystrophy disorders

    Drug Discovery Today: Technologies, Vol. 10, Núm. 1